Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies

Volume: 94, Issue: 22
Published: Jun 2, 2020
Abstract

Objective

To determine the frequency and significance of concurrent glial (glial-Ab) or neuronal-surface (NS-Ab) antibodies in patients with anti–NMDA receptor (NMDAR) encephalitis.

Methods

Patients were identified during initial routine screening of a cohort (C1) of 646 patients consecutively diagnosed with anti-NMDAR encephalitis and another cohort (C2) of 200 patients systematically rescreened. Antibodies were determined...
Paper Details
Title
Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies
Published Date
Jun 2, 2020
Journal
Volume
94
Issue
22
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.